Novo Nordisk A/S buy Snowman
Start price
19.07.21
/
50%
€75.34
Target price
19.07.22
€82.00
Performance (%)
50.65%
End price
20.07.22
€113.50
Summary
This prediction ended on 20.07.22 with a price of €113.50. With a performance of 50.65% the BUY prediction by Snowman was a big success. Dividends of €7.46 are taken into consideration when calculating the performance. Snowman has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
Comments by Snowman for this prediction
In the thread Novo Nordisk A/S diskutieren
In the thread Trading Novo Nordisk A/S
Die von Snowman gewählte maximale Laufzeit wurde überschritten